Videos
A Case of HR+ Metastatic Breast Cancer
JAK Inhibition for the Management of Primary Myelofibrosis
Primary Myelofibrosis
CLL Case Review: IgHV-Unmutated Therapy Options
David S. Hong, MD, discusses the potential for other TRK inhibitors in the treatment landscape for patients with thyroid cancer after the approval of larotrectinib.
Andre Goy, MD, discusses a few combinations that are being investigated for the treatment of patients with relapsed/refractory mantle cell lymphoma.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Telehealth May Offer a Path to More Equitable Myeloma Transplant Access
2
FDA Application Withdrawn for I-DXd in Small Cell Lung Cancer
3
Zabilugene Almadenorepvec Plus Chemo Shows Survival Gains in Metastatic PDAC
4
Oral Azacitidine-Cedazuridine Meets Pharmacokinetic Goal in Phase 3 MDS/CMML Trial
5